MAQS has advised IRLAB Therapeutics AB. IRLAB Therapeutics AB has been admitted to trading the Company’s shares of series A on Nasdaq Stockholm Main Market. IRLAB…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now